Recon: Supreme Court seems skeptical of mifepristone challenge; Lawmakers query FDA on Neuralink inspection
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States